Related references
Note: Only part of the references are listed.The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours
Aldo Scarpa
ANNALES D ENDOCRINOLOGIE (2019)
Comprehensive evaluation and characterisation of short read general-purpose structural variant calling software
Daniel L. Cameron et al.
NATURE COMMUNICATIONS (2019)
Molecular prognostic factors in small-Intestinal neuroendocrine tumours
K. G. Samsom et al.
ENDOCRINE CONNECTIONS (2019)
Pan-cancer whole-genome analyses of metastatic solid tumours
Peter Priestley et al.
NATURE (2019)
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine
Michele Simbolo et al.
VIRCHOWS ARCHIV (2018)
In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components
Christine Woischke et al.
MODERN PATHOLOGY (2017)
Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains
Maike Nieser et al.
NEUROENDOCRINOLOGY (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Cell Cycle Protein Expression in Neuroendocrine Tumors Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index
Yan Shi et al.
PANCREAS (2017)
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
Anna Karpathakis et al.
CLINICAL CANCER RESEARCH (2016)
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas
Laura H. Tang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
Namrata Vijayvergia et al.
BRITISH JOURNAL OF CANCER (2016)
Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets
Ellinor Andersson et al.
MODERN PATHOLOGY (2016)
Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors
Joakim Crona et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors
Shreya Mehta et al.
MEDICINE (2015)
Somatic alterations of CDKN1B are associated with small bowel neuroendocrine tumors
Jessica E. Maxwell et al.
CANCER GENETICS (2015)
Exploring the Rising Incidence of Neuroendocrine Tumors: A Population-Based Analysis of Epidemiology, Metastatic Presentation, and Outcomes
Julie Hallet et al.
CANCER (2015)
Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
A. Delgado Verdugo et al.
HORMONE AND METABOLIC RESEARCH (2015)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization
Jamileh Hashemi et al.
BMC CANCER (2013)
Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registry
Catharina M. Korse et al.
EUROPEAN JOURNAL OF CANCER (2013)
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Joshua M. Francis et al.
NATURE GENETICS (2013)
Somatostatin Receptor Subtype 2A Immunohistochemistry Using a New Monoclonal Antibody Selects Tumors Suitable for In Vivo Somatostatin Receptor Targeting
Meike Koerner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Common Pathogenetic Mechanism Involving Human Chromosome 18 in Familial and Sporadic Ileal Carcinoid Tumors
Janet L. Cunningham et al.
GENES CHROMOSOMES & CANCER (2011)
High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids
Ellinor Andersson et al.
ENDOCRINE-RELATED CANCER (2009)
High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss
Matthew H. Kulke et al.
GENES CHROMOSOMES & CANCER (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors
Do Ha Kim et al.
GENES CHROMOSOMES & CANCER (2008)
Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors
GG Wang et al.
MODERN PATHOLOGY (2005)
Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract
D Furlan et al.
CLINICAL CANCER RESEARCH (2004)
Chromosome 18 deletions are common events in classical midgut carcinoid tumors
RM Löllgen et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
